Literature DB >> 17191082

Mitogen-activated protein kinase upregulation reduces renal D1 receptor affinity and G-protein coupling in obese rats.

A A Banday1, F R Fazili, A Marwaha, M F Lokhandwala.   

Abstract

Reactive oxygen species play a key role in pathophysiology of cardiovascular diseases by modulating G-protein-coupled receptor signaling. We have shown that treatment of animal models of diabetes and aging with tempol decreases oxidative stress and restores renal dopamine D1 receptor (D1R) function. In present study, we determined whether oxidation of D1R and upregulation of mitogen-activated protein kinases (MAPK) were responsible for decreased D1R signaling in obese animals. Male lean and obese Zucker rats were supplemented with antioxidants tempol or lipoic acid for 2 weeks. Compared to lean, obese animals were hyperglycemic and hyperinsulinemic with increased oxidative stress, D1R oxidation and decreased glutathione levels. These animals had decreased renal D1R affinity and basal coupling to G-proteins. SKF-38393, a D1R agonist failed to stimulate G-proteins and adenylyl cyclase. Obese animals showed marked increase in renal MAPK activities. Treatment of obese rats with tempol or lipoic acid decreased blood glucose, reduced oxidative stress, and restored the basal D1R G-protein coupling. Antioxidants also normalized MAPK activities and restored D1R affinity and SKF-38393 induced D1R G-protein coupling and adenylyl cyclase stimulation. These studies show that D1R oxidation and MAPK upregulation contribute to D1R dysfunction in obese animals. Consequently, antioxidants while reducing the oxidative stress normalize the MAPK activities and restore D1R signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17191082     DOI: 10.1038/sj.ki.5002055

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  10 in total

1.  High glucose up-regulates angiotensin II subtype 2 receptors via interferon regulatory factor-1 in proximal tubule epithelial cells.

Authors:  Quaisar Ali; Rifat Sabuhi; Tahir Hussain
Journal:  Mol Cell Biochem       Date:  2010-07-02       Impact factor: 3.396

Review 2.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

Review 3.  Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.

Authors:  John J Gildea
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-01       Impact factor: 2.894

4.  Resveratrol restored Nrf2 function, reduced renal inflammation, and mitigated hypertension in spontaneously hypertensive rats.

Authors:  Apurva A Javkhedkar; Yasmir Quiroz; Bernardo Rodriguez-Iturbe; Nosratola D Vaziri; Mustafa F Lokhandwala; Anees A Banday
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-03-11       Impact factor: 3.619

5.  Early development of podocyte injury independently of hyperglycemia and elevations in arterial pressure in nondiabetic obese Dahl SS leptin receptor mutant rats.

Authors:  Kasi C McPherson; Lateia Taylor; Ashley C Johnson; Sean P Didion; Aron M Geurts; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2016-07-27

Review 6.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

Review 7.  Renal Dopamine Receptors and Oxidative Stress: Role in Hypertension.

Authors:  Jian Yang; Van Anthony M Villar; Pedro A Jose; Chunyu Zeng
Journal:  Antioxid Redox Signal       Date:  2020-05-29       Impact factor: 8.401

8.  Nrf2 inhibition induces oxidative stress, renal inflammation and hypertension in mice.

Authors:  Zeba Farooqui; Razia Sultana Mohammad; Mustafa F Lokhandwala; Anees Ahmad Banday
Journal:  Clin Exp Hypertens       Date:  2020-10-18       Impact factor: 1.749

9.  Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats.

Authors:  Jinjuan Fu; Yu Han; Hongyong Wang; Zhen Wang; Yukai Liu; Xingjian Chen; Yue Cai; Weiwei Guan; Di Yang; Laureano D Asico; Lin Zhou; Pedro A Jose; Chunyu Zeng
Journal:  Cardiovasc Diabetol       Date:  2014-02-22       Impact factor: 9.951

Review 10.  Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes.

Authors:  Bingxuan Wang; P Charukeshi Chandrasekera; John J Pippin
Journal:  Curr Diabetes Rev       Date:  2014-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.